COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment Scales

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03273179
Recruitment Status : Unknown
Verified February 2018 by Ji Xunming, Capital Medical University.
Recruitment status was:  Recruiting
First Posted : September 6, 2017
Last Update Posted : February 5, 2018
Sponsor:
Information provided by (Responsible Party):
Ji Xunming, Capital Medical University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
This is a single-center, retrospective, open-label study. This study is planned to investigate the accuracy of mRS and NIHSS, comparing with the accuracy of CSF pressure and papilledema grade in assessing cerebral venous sinus thrombosis.

Condition or disease
Cerebral Venous Sinus Thrombosis CSF Pressure Increased Papilledema

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment
Actual Study Start Date : June 1, 2017
Estimated Primary Completion Date : April 1, 2018
Estimated Study Completion Date : July 1, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Blood Clots

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. baseline CSF pressure [ Time Frame: baseline ]
    CSF pressure at baseline

  2. baseline mRS [ Time Frame: baseline ]
    mRS at baseline

  3. baseline papilledema grade [ Time Frame: baseline ]
    Frisen grade of papilledema at baseline


Secondary Outcome Measures :
  1. baseline NIHSS [ Time Frame: baseline ]
    NIH Stroke Scale at baseline


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
All individual with confirmed diagnosis of CVST are eligible for this research
Criteria

Inclusion Criteria:

  • confirmed diagnosis of CVST by head MRI, DSA or MRV onset of CVST within one month

Exclusion Criteria:

  • unable to complete examinations unable to complete follow-ups
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03273179


Contacts
Layout table for location contacts
Contact: Xunming Ji +86-83198952 jixunming@vip.163.com
Contact: Zhen Zhang gzhenzhang@sina.com

Locations
Layout table for location information
China
Xuanwu Hospital Capital Medical University Recruiting
Beijing, China
Contact: Zhang Zhen       gzhenzhang@sina.com   
Sponsors and Collaborators
Capital Medical University
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Ji Xunming, Professor, Capital Medical University
ClinicalTrials.gov Identifier: NCT03273179    
Other Study ID Numbers: CVST-RCAS
First Posted: September 6, 2017    Key Record Dates
Last Update Posted: February 5, 2018
Last Verified: February 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Ji Xunming, Capital Medical University:
cerebral venous sinus thrombosis
CSF pressure
modified Rankin Scale
papilledema
NIHSS
Additional relevant MeSH terms:
Layout table for MeSH terms
Sinus Thrombosis, Intracranial
Papilledema
Intracranial Hypertension
Thrombosis
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Intracranial Thrombosis
Intracranial Embolism and Thrombosis
 Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Thromboembolism
Optic Nerve Diseases
Cranial Nerve Diseases
Eye Diseases